Biotech Showcase is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Franz-Werner Haas
COO at CureVac

Profile

Franz-Werner Haas is far from your typical office guy – this highly qualified lawyer is far too dynamic to be just ordinary. As Chief Operating Officer on the Management Board, he is in charge of four very different areas: Corporate Development, HR, Intellectual Property, and Legal. He is acting as the organizational backbone of CureVac and is responsible for ensuring that everything runs smoothly. In the end, this means that his mission is the further development of the company in terms of business and organization. Getting new staff on board, converting the knowledge created by the company into patents, and negotiating partnerships are all among his tasks, and he always performs them with a view to developing possible mRNA products for the future market. Franz-Werner Haas is approachable and communicative, well organized, and always open to new ideas, and this really shows in his work. Not to mention his infectious enthusiasm and his positive nature. He quickly finds a way to engage with both people and with complex, challenging topics. That is why he has been fascinated by the RNA molecule for years. Together with the entire team of RNA people, he strives to ensure that this fascination will soon translate into a new medical reality.  Franz-Werner Haas, LLD, LLM, Chief Operating Officer joined CureVac in June 2012. He is responsible for Corporate Development, HR, IP and Legal. Before joining CureVac, he was Vice President Operations and Chief Compliance Officer of SYGNIS Pharma AG, where he was also responsible for the execution of M&A- and capital market transactions. Franz-Werner Haas started his professional career as assistant to the Management of a privately held holding company before he assumed several management positions in the Life Science Industry, including Vice President and General Counsel of LION bioscience and General Counsel of Sirona Dental Systems. He studied law at the University of Saarbruecken, K.U. Leuven and the University of Edinburgh (LL.M.).

Agenda Sessions

  • The year of RNA and the start of a new era - Hilton Union Square

    ,

Speakers at this event